Revolutionizing Pharmaceuticals in Space

This chapter explores Varda's recent $187 million Series C funding aimed at developing drug formulations via microgravity in space. It highlights the significance of a biologics lab for testing drugs, emphasizing how microgravity enhances the understanding of chemical reactions in drug formulations. The discussion also covers the advancements in reusable rocket technology that expand access to microgravity for pharmaceutical development.